Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chongqing Mingdao Haoyue Biotechnology Co., Ltd.
0 Patents (Medical) associated with Chongqing Mingdao Haoyue Biotechnology Co., Ltd.
100 Deals associated with Chongqing Mingdao Haoyue Biotechnology Co., Ltd.
100 Translational Medicine associated with Chongqing Mingdao Haoyue Biotechnology Co., Ltd.